There has been a significant amount of controversy over the past year concerning CBD oil and its legality. The Drug Enforcement Agency (DEA) earlier in 2017 took it upon themselves to classify CBD oil as a Schedule 1 controlled substance. This classifies CBD oil as the same product as THC oils or marijuana.
Almost immediately a lawsuit was filed in the 9th Circuit Court stating that the DEA did not have the authority to classify hemp products in this manner and that in doing so they have harmed a legal industry protected by the Industrial Hemp Legislation and the Farm Bill. Additionally, this regulatory agency was chastised for making laws when changing the classification of this product, an authority that they do not hold.
Misinformation Is Abundant
Information surrounding CBD oil can be misleading, especially if it is not from an authoritative source. Many people confuse CBD oil with a similar product known as THC oil or marijuana. CBD oil is a natural product derived from the hemp plant, a form of cannabis, but it is not derived from marijuana.
To be considered pure CBD oil it must be cultivated according to the regulations of the Industrial Hemp legislation and Section 7606 of the Farm Bill. These are both Congressional laws. CBD oil must contain less than .03 percent THC, with a preference of zero THC to be in compliance with these laws. CBD oil does not have any psychoactive (high) effects on anyone who consumes the product.
According to the DEA, a Schedule I Drug is defined as “Drugs, Substances or Chemicals that are defined as drugs that have no current accepted medical use and have a high potential for abuse. Examples of Schedule 1 drugs include LSD, Heroin, Ecstasy, Marijuana, Methaqualone and Peyote.”
CBD oil is not addictive and does not produce a high. It has many medical based uses, and many doctors who have avoided alternative medicines in the past are now actively prescribing this product because of its many benefits.
U.S. Judiciary Committee Wants Answers
Representative Bob Goodlatte (R) Virginia who sits on the United States Judiciary Committee has raised the issue of Industrial Hemp and Cannabinoid products derived from hemp (CBD oil) during a recent committee meeting. Speaking directly to Chuck Rosenberg, Acting Administrator of the DEA, Chairman Goodlatte asked what the status was concerning cannabinoid products.
Mr. Rosenberg replied that hemp is still classified as a Schedule 1 substance. However, he further stated that any hemp farmer who remains in compliance with Section 7606 of the Farm Bill is producing legal hemp and hemp products.
Representative Goodlatte further stated that he wanted to make sure that hemp farmers were not being harassed and that accessibility to a product that provides a lot of help to people should not be made impossible to obtain.
BeFit CBD Oil is pleased to inform all of its clients that it is in compliance with Section 7606 of the Farm Bill and meets or exceeds all requirements for Industrial Hemp farming. With a fully integrated supply channel, our medicinal grade hemp producers grow, process, and extract all CBD oil products to ensure products are the highest quality and always in compliance with federal laws. We will continue to operate in this manner to ensure that our product remains available to anyone who desires to benefit from CBD oil.
The CBD market will be a $2.1 billion market by 2020.